supply of - inj tirzepatide 2.5 mg , inj tirzepatide 5 mg , inj tirzepatide7. 5 mg , inj tirzepatide 10 mg , tab letermovir 240 mg , tab trametinib 2 mg , inj romosozumab 210 mg , inj toripalimab 240 mg - medical stores | quantity - 330

Indian Army has invited bids for the supply of - inj tirzepatide 2.5 mg , inj tirzepatide 5 mg , inj tirzepatide7. 5 mg , inj tirzepatide 10 mg , tab letermovir 240 mg , tab trametinib 2 mg , inj romosozumab 210 mg , inj toripalimab 240 mg - medical stores | quantity - 330. The estimated project cost is ₹0.21 Cr. Please refer to the tender document for EMD details. Interested bidders can submit applications until 26 September 2026, with the technical opening scheduled for 26 September 2026.